Have a personal or library account? Click to login
MIMA-9, a valuable antibody for screening for rare donors Cover

MIMA-9, a valuable antibody for screening for rare donors

Paid access
|Oct 2020

Abstract

Since monoclonal antibodies (Mabs) are potentially available in an unlimited volume, they can be used to screen numerous donor blood samples to identify antigen-negative donors. We have used a Mab (MIMA-9) with characteristics that allow for the simultaneous screening of RBCs of any ABO group for high-incidence antigennegativity in the Kell and Gerbich blood group systems. MIMA-9, a murine IgG2a antibody, previously shown to facilitate the identification of K+k–, Kp(a+b–), K0, McLeod, or Ge:–3 red blood cells (RBCs), was used in MTS gel cards containing anti-mouse IgG as the second antibody to test 1134 K– donors. Among the 1134 donors tested, we found one Kp(a+b–) and one Ge:–2,–3,4 donor. If random donor samples had been used instead of preselecting for K–, we would have expected to identify two K+k– donors. One reagent (MIMA-9) can be used to simultaneously screen for K+k–, Kp(a+b–), K0, McLeod, and Ge:–3 RBCs and thereby conserve rare antisera. Inclusion of anti-mouse IgG in gel cards allowed for rapid screening. MIMA-9 is also a useful reagent to type RBCs with a positive direct antiglobulin test. This antibody is available to donor screening laboratories at no cost for this specific use. Immunohematology 2002:18:43–45.

DOI: https://doi.org/10.21307/immunohematology-2019-508 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 43 - 45
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 E. Tossas, R. Øyen, G.R. Halverson, H. Malyska, M.E. Reid, published by American National Red Cross
This work is licensed under the Creative Commons License.